Literature DB >> 24296657

Neurometabolic disease: Treating mitochondrial diseases with mTOR inhibitors--a potential treatment for Leigh syndrome?

Tim Geach.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24296657     DOI: 10.1038/nrneurol.2013.251

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome.

Authors:  Simon C Johnson; Melana E Yanos; Ernst-Bernhard Kayser; Albert Quintana; Maya Sangesland; Anthony Castanza; Lauren Uhde; Jessica Hui; Valerie Z Wall; Arni Gagnidze; Kelly Oh; Brian M Wasko; Fresnida J Ramos; Richard D Palmiter; Peter S Rabinovitch; Philip G Morgan; Margaret M Sedensky; Matt Kaeberlein
Journal:  Science       Date:  2013-11-14       Impact factor: 47.728

  1 in total
  1 in total

1.  In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndrome.

Authors:  Kuan-Chung Chen; Wen-Yuan Lee; Hsin-Yi Chen; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-23       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.